Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis
Aging-elevated DNMT3A R882H-driven clonal hematopoiesis (CH) is a risk factor for myeloid malignancies remission and overall survival. Although some studies were conducted to investigate this phenomenon, the exact mechanism is still under debate. In this study, we observed that DNMT3A R878H bone mar...
Main Authors: | Min Liao, Ruiqing Chen, Yang Yang, Hanqing He, Liqian Xu, Yuxuan Jiang, Zhenxing Guo, Wei He, Hong Jiang, Jianwei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-02-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383521003579 |
Similar Items
-
Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
by: Shengfang Wang, et al.
Published: (2022-04-01) -
Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
by: Charles Gaulin, et al.
Published: (2022-07-01) -
DNMT3A dysfunction promotes neuroinflammation and exacerbates acute ischemic stroke
by: Tian‐Jie Lyu, et al.
Published: (2024-07-01) -
New approaches to idiopathic neutropenia in the era of clonal hematopoiesis
by: Olisaemeka D. Ogbue, et al.
Published: (2023-04-01) -
Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
by: Stefan Kuhnert, et al.
Published: (2022-07-01)